Related Experiment Video
Updated: Apr 26, 2026

Induction and Validation of Cellular Senescence in Primary Human Cells
Published on: June 20, 2018
mTOR Signaling from Cellular Senescence to Organismal Aging
Shaohua Xu1, Ying Cai2, Yuehua Wei3
1Gladstone Institute of Cardiovascular Disease, University of California San Francisco, San Francisco, CA94102, USA.
Abstract:
The TOR (target of rapamycin) pathway has been convincingly shown to promote aging in various model organisms. In mice, inhibiting mTOR (mammalian TOR) by rapamycin treatment later in life can significantly extend lifespan and mitigate multiple age-related diseases. However, the underlying mechanisms are poorly understood. Cellular senescence is strongly correlated to organismal aging therefore providing an attractive model to examine the mechanisms by which mTOR inhibition contributes to longevity and delaying the onset of related diseases. In this review, we examine the connections between mTOR and cellular senescence and discuss how understanding cellular senescence on the aspect of mTOR signaling may help to fully appreciate its role in the organismal aging. We also highlight the opposing roles of senescence in various human diseases and discuss the caveats in interpreting the emerging experimental data.
Insights
Inhibiting the target of rapamycin (TOR) pathway with rapamycin extends lifespan and delays aging-related diseases in mice. This review explores how targeting cellular senescence via mTOR inhibition may unlock longevity secrets.
Area of Science:
- Gerontology
- Cellular Biology
- Molecular Biology
Background:
- The target of rapamycin (TOR) pathway is implicated in promoting aging across diverse organisms.
- Rapamycin treatment in mice extends lifespan and mitigates age-related diseases, but mechanisms remain unclear.
- Cellular senescence is a hallmark of aging, making it a key model for studying aging mechanisms.
Purpose of the Study:
- To review the relationship between mTOR signaling and cellular senescence.
- To explore how inhibiting mTOR impacts longevity and age-related diseases through cellular senescence.
- To discuss the dual role of senescence in human diseases and interpret experimental findings.
Main Methods:
- Literature review focusing on mTOR signaling and cellular senescence.
- Analysis of studies investigating rapamycin's effects on aging and senescence.
- Examination of the interplay between mTOR pathways and senescence markers.
Main Results:
- mTOR inhibition influences cellular senescence, a key factor in aging.
- Understanding senescence in the context of mTOR signaling is crucial for comprehending organismal aging.
- Senescence exhibits complex, sometimes opposing, roles in various human diseases.
Conclusions:
- Targeting cellular senescence via mTOR inhibition presents a promising avenue for promoting longevity.
- Further research is needed to fully elucidate the mechanisms linking mTOR, senescence, and aging.
- Careful interpretation of data is essential due to the multifaceted roles of senescence in disease.
More Related Videos
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
PI3K/mTOR/AKT Signaling Pathway
Replicative Cell Senescence
Replicative Cell Senescence
Mitochondria

